The symptoms may include:
?skin rash, itching, or hives
?swelling of the face, lips, tongue, or other parts of the body
?difficulty breathing, wheezing, or respiratory problems
?Fever (high temperature) without explanation and feeling weak, especially when standing.
Other side effects include:
Very frequent (may affect more than 1in10 people):
burning or irritation, photophobia/sensitivity to light, or sensation of having something in the eye (superficial punctate keratopathy)
This usually does not require discontinuing treatment and improves immediately
Infrequent (may affect more than 1in100 people):
mild sensation of burning or irritation that occurs immediately after application
swollen eyes, tearing (conjunctivitis)
Rare (may affect more than 1in1000 people):
swollen, red, irritated, itchy eyelids (blepharitis)
If any of these effects worsen, or if you notice side effects not mentioned in this prospectus, consult your doctor or pharmacist.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report it directly to theSpanish System of Pharmacovigilance of
Medicines for Human Use:www.notificaRAM.es
By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Conservebelow 25 °C.
Keep this medication out of the sight and reach of children.
Do not use this medicationafterthe expiration date that appears on the label and packaging. The expiration date is the last day of the month indicated.
Do not use it for more than 4 weeksafter openingfor the first time.
Medicines should not be disposed of through drainsnor intrash. Dispose of packaging and medications that you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications that you no longer need. By doing so, you will help protect the environment.
What Xorox contains :
Appearance of Xorox and content of the packaging
1 box contains an aluminium tube with a nozzle (tip) and a white polyethylene cap with 4.5 g of white to greyish white ointment.
Holder of the marketing authorization and manufacturer
AGEPHA Pharma s.r.o
Dialnicná cesta 5
Senec
903 01
Slovakia
This leaflet was last reviewed in: March2019
Detailed and updated information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Products (AEMPS)shttp://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.